Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Voxelotor | hsa00030 | Pentose phosphate pathway | 2.93E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Voxelotor | hsa00040 | Pentose and glucuronate interconversions | 4.00E-02 | 1 | P15121 | AKR1B1 | More | | Voxelotor | hsa00052 | Galactose metabolism | 2.00E-02 | 3 | P08237, P19367, Q14376 | PFKM, HK1, GALE | More | | Voxelotor | hsa00220 | Arginine biosynthesis | 2.93E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Voxelotor | hsa00380 | Tryptophan metabolism | 2.05E-05 | 2 | Q16613, P46952 | AANAT, HAAO | More | | Voxelotor | hsa00500 | Starch and sucrose metabolism | 1.47E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Voxelotor | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Voxelotor | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 4.51E-05 | 1 | Q9Y2C2 | UST | More | | Voxelotor | hsa00565 | Ether lipid metabolism | 1.25E-02 | 2 | Q9Y6K0, Q8N661 | CEPT1, TMEM86B | More | | Voxelotor | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Voxelotor | hsa00591 | Linoleic acid metabolism | 1.48E-03 | 1 | P11712 | CYP2C9 | More | | Voxelotor | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.93E-06 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Voxelotor | hsa00730 | Thiamine metabolism | 4.07E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Voxelotor | hsa00785 | Lipoic acid metabolism | 1.84E-05 | 2 | O43766, Q9Y234 | LIAS, LIPT1 | More | | Voxelotor | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | | Voxelotor | hsa00830 | Retinol metabolism | 1.10E-03 | 2 | P11766, P00352 | ADH5, ALDH1A1 | More | | Voxelotor | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Voxelotor | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.38E-04 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | | Voxelotor | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Voxelotor | hsa00983 | Drug metabolism - other enzymes | 3.59E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Voxelotor | hsa01100 | Metabolic pathways | 2.42E-03 | 48 | Q9NR34, O43766, Q9Y234, P35790, P05089, Q16772, P30041, P19367, Q14642, P32320, P20839, P00918, P22748, P55809, P06280, Q16875, O43286, O43451, Q9Y6K0, Q14376, P48506, P05186, P24666, P08237, O95861, P21399, P07101, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P48651, P57054, Q9UNP4, Q9H4F1, Q9BX95, P32321, P34059, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P35573, P06737, Q969G6, P14927, Q13029 | MAN1C1, LIAS, LIPT1, CHKA, ARG1, GSTA3, PRDX6, HK1, INPP5A, CDA, IMPDH1, CA2, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, CEPT1, GALE, GCLC, ALPL, ACP1, PFKM, BPNT1, ACO1, TH, MCCC2, ACSL1, AMACR, SGMS1, PTDSS1, PIGP, ST3GAL5, ST6GALNAC4, SGPP1, DCTD, GALNS, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, AGL, PYGL, RFK, UQCRB, PRDM2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P68871 | HBB | Hemoglobin subunit beta | O43766 | LIAS | Lipoyl synthase, mitochondrial | -0.735 | P68871 | HBB | Hemoglobin subunit beta | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.835 | P68871 | HBB | Hemoglobin subunit beta | P35790 | CHKA | Choline kinase alpha | -0.808 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P68871 | HBB | Hemoglobin subunit beta | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.757 | P68871 | HBB | Hemoglobin subunit beta | P30041 | PRDX6 | Peroxiredoxin-6 | 0.887 | P68871 | HBB | Hemoglobin subunit beta | P19367 | HK1 | Hexokinase-1 | 0.708 | P68871 | HBB | Hemoglobin subunit beta | Q14642 | INPP5A | Inositol polyphosphate-5-phosphatase A | -0.736 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P68871 | HBB | Hemoglobin subunit beta | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.835 | P68871 | HBB | Hemoglobin subunit beta | P00918 | CA2 | Carbonic anhydrase 2 | 0.72 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P68871 | HBB | Hemoglobin subunit beta | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.812 | P68871 | HBB | Hemoglobin subunit beta | Q14376 | GALE | UDP-glucose 4-epimerase | 0.726 | P68871 | HBB | Hemoglobin subunit beta | P48506 | GCLC | Glutamate--cysteine ligase catalytic subunit | -0.896 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P68871 | HBB | Hemoglobin subunit beta | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.746 | P68871 | HBB | Hemoglobin subunit beta | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | -0.705 | P68871 | HBB | Hemoglobin subunit beta | P21399 | ACO1 | Cytoplasmic aconitate hydratase | -0.709 | P68871 | HBB | Hemoglobin subunit beta | P07101 | TH | Tyrosine 3-monooxygenase | 0.825 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P68871 | HBB | Hemoglobin subunit beta | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.727 | P68871 | HBB | Hemoglobin subunit beta | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.749 | P68871 | HBB | Hemoglobin subunit beta | P48651 | PTDSS1 | Phosphatidylserine synthase 1 | 0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | P68871 | HBB | Hemoglobin subunit beta | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | 0.821 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | P68871 | HBB | Hemoglobin subunit beta | P34059 | GALNS | N-acetylgalactosamine-6-sulfatase | -0.813 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | P68871 | HBB | Hemoglobin subunit beta | P35573 | AGL | Glycogen debranching enzyme | -0.739 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P68871 | HBB | Hemoglobin subunit beta | Q969G6 | RFK | Riboflavin kinase | 0.817 | P68871 | HBB | Hemoglobin subunit beta | P14927 | UQCRB | Cytochrome b-c1 complex subunit 7 | 0.765 | P68871 | HBB | Hemoglobin subunit beta | Q13029 | PRDM2 | PR domain zinc finger protein 2 | 0.762 |
| Voxelotor | hsa01200 | Carbon metabolism | 2.71E-02 | 4 | P37837, P60891, P11766, P49448 | TALDO1, PRPS1, ADH5, GLUD2 | More | | Voxelotor | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.51E-02 | 2 | P21399, P50213 | ACO1, IDH3A | More | | Voxelotor | hsa01230 | Biosynthesis of amino acids | 3.05E-02 | 4 | P08237, P21399, P50213, P37837 | PFKM, ACO1, IDH3A, TALDO1 | More | | Voxelotor | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Voxelotor | hsa03008 | Ribosome biogenesis in eukaryotes | 1.46E-02 | 4 | Q9NYH9, P78345, Q9BVP2, Q9GZY0 | UTP6, RPP38, GNL3, NXF2; NXF2B | More | | Voxelotor | hsa03010 | Ribosome | 1.12E-04 | 7 | P40429, P46777, Q07020, Q9UHA3, P27635, P05386, P62249 | RPL13A, RPL5, RPL18, RSL24D1, RPL10, RPLP1, RPS16 | More | | Voxelotor | hsa03013 | RNA transport | 1.93E-03 | 10 | P52298, P61326, Q9GZY0, Q7Z3B4, Q14152, O75822, P78345, Q14240, Q9Y6A5, Q53GS7 | NCBP2, MAGOH, NXF2; NXF2B, NUP54, EIF3A, EIF3J, RPP38, EIF4A2, TACC3, GLE1 | More | | Voxelotor | hsa03015 | mRNA surveillance pathway | 9.78E-03 | 6 | O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7 | RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1 | More | | Voxelotor | hsa03040 | Spliceosome | 2.03E-09 | 17 | Q14562, O43143, O60508, P17844, P08579, P26368, P51991, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, U2AF2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.76 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.787 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.712 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.822 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Voxelotor | hsa03050 | Proteasome | 1.79E-03 | 1 | P55036 | PSMD4 | More | | Voxelotor | hsa03410 | Base excision repair | 7.59E-03 | 1 | P27695 | APEX1 | More | | Voxelotor | hsa04010 | MAPK signaling pathway | 1.15E-02 | 9 | Q02750, Q15283, P09619, Q8IZS8, P54284, Q9H2K8, O43283, Q12933, P51812 | MAP2K1, RASA2, PDGFRB, CACNA2D3, CACNB3, TAOK3, MAP3K13, TRAF2, RPS6KA3 | More | | Voxelotor | hsa04012 | ErbB signaling pathway | 3.15E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Voxelotor | hsa04014 | Ras signaling pathway | 1.98E-03 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Voxelotor | hsa04015 | Rap1 signaling pathway | 2.49E-03 | 11 | P09603, P20827, P49767, Q9GZP0, Q96FS4, P11215, Q13009, Q7LDG7, P42338, Q86WV1, P19174 | CSF1, EFNA1, VEGFC, PDGFD, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, SKAP1, PLCG1 | More | | Voxelotor | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | | Voxelotor | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Voxelotor | hsa04064 | NF-kappa B signaling pathway | 1.14E-03 | 11 | Q13489, O00463, Q13546, P14778, Q9UDY8, Q13077, Q16548, Q8WV28, P24522, P09341, Q9UNE0 | BIRC3, TRAF5, RIPK1, IL1R1, MALT1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1, EDAR | More | | Voxelotor | hsa04070 | Phosphatidylinositol signaling system | 4.86E-02 | 3 | P0DP23, P42338, P27987 | CALM1, PIK3CB, ITPKB | More | | Voxelotor | hsa04071 | Sphingolipid signaling pathway | 3.31E-03 | 6 | P17252, Q16537, Q9BX95, Q16539, P04637, P10415 | PRKCA, PPP2R5E, SGPP1, MAPK14, TP53, BCL2 | More | | Voxelotor | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Voxelotor | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Voxelotor | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Voxelotor | hsa04145 | Phagosome | 3.27E-04 | 9 | P63261, Q15080, P14598, Q13509, P68371, P05164, O60603, P35443, P13765 | ACTG1, NCF4, NCF1, TUBB3, TUBB2C, MPO, TLR2, THBS4, HLA-DOB | More | | Voxelotor | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Voxelotor | hsa04151 | PI3K-Akt signaling pathway | 2.70E-06 | 23 | P62753, P42338, P43657, P01106, P27348, P09603, P20827, P49767, Q9GZP0, P07900, P08238, Q8WYR1, P63218, P50151, P13612, O15335, Q13751, P22105, P14784, Q99941, P18848, O00141, P30281 | RPS6, PIK3CB, P2RY5, MYC, YWHAQ, CSF1, EFNA1, VEGFC, PDGFD, HSP90AA1, HSP90AB1, PIK3R5, GNG5, GNG10, ITGA4, CHAD, LAMB3, TNXB, IL2RB, CREBL1, ATF4, SGK, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.813 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.784 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P01106 | MYC | Myc proto-oncogene protein | -0.707 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | 0.73 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P20827 | EFNA1 | Ephrin-A1 | -0.763 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | Q9GZP0 | PDGFD | Platelet-derived growth factor D | -0.7 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.813 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.838 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.779 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P13612 | ITGA4 | Integrin alpha-4 | -0.804 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O15335 | CHAD | Chondroadherin | -0.792 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.805 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.867 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.779 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.701 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Voxelotor | hsa04211 | Longevity regulating pathway | 9.85E-04 | 6 | Q12778, P51828, Q99941, P18848, Q9UEF7, Q96KQ7 | FOXO1, ADCY7, CREBL1, ATF4, KL, EHMT2 | More | | Voxelotor | hsa04216 | Ferroptosis | 1.51E-02 | 3 | P04637, Q9H1Y0, P33121 | TP53, ATG5, ACSL1 | More | | Voxelotor | hsa04217 | Necroptosis | 2.93E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Voxelotor | hsa04260 | Cardiac muscle contraction | 1.81E-04 | 4 | Q8IZS8, P54284, P09493, P14927 | CACNA2D3, CACNB3, TPM1, UQCRB | More | | Voxelotor | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Voxelotor | hsa04360 | Axon guidance | 2.47E-03 | 7 | P16333, P20827, O95631, P42338, P07332, P23528, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1 | More | | Voxelotor | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Voxelotor | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Voxelotor | hsa04520 | Adherens junction | 9.72E-03 | 5 | Q09472, P19784, P61586, P60709, P63261 | EP300, CSNK2A2, RHOA, ACTB, ACTG1 | More | | Voxelotor | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Voxelotor | hsa04540 | Gap junction | 3.53E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Voxelotor | hsa04610 | Complement and coagulation cascades | 5.02E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Voxelotor | hsa04613 | Neutrophil extracellular trap formation | 2.43E-03 | 14 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P21462, P63261 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1, ACTG1 | More | | Voxelotor | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Voxelotor | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Voxelotor | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Voxelotor | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Voxelotor | hsa04640 | Hematopoietic cell lineage | 5.83E-03 | 7 | P13612, P11215, P07766, P01730, P06127, P09564, P09603 | ITGA4, ITGAM, CD3E, CD4, CD5, CD7, CSF1 | More | | Voxelotor | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | | Voxelotor | hsa04657 | IL-17 signaling pathway | 4.55E-02 | 5 | O00463, Q16539, P49841, P09341, P14780 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9 | More | | Voxelotor | hsa04658 | Th1 and Th2 cell differentiation | 9.35E-03 | 5 | P07766, P19174, P06239, P14784, Q13761 | CD3E, PLCG1, LCK, IL2RB, RUNX3 | More | | Voxelotor | hsa04659 | Th17 cell differentiation | 2.19E-03 | 9 | P19174, P42224, P14784, P14778, P40189, P84022, Q13485, P08238, P07766 | PLCG1, STAT1, IL2RB, IL1R1, IL6ST, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Voxelotor | hsa04662 | B cell receptor signaling pathway | 9.03E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Voxelotor | hsa04664 | Fc epsilon RI signaling pathway | 1.09E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Voxelotor | hsa04666 | Fc gamma R-mediated phagocytosis | 8.47E-04 | 6 | P42338, P23528, P49006, P06396, P14598, P17252 | PIK3CB, CFL1, MARCKSL1, GSN, NCF1, PRKCA | More | | Voxelotor | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Voxelotor | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Voxelotor | hsa04724 | Glutamatergic synapse | 3.24E-02 | 3 | P43003, P50151, P15104 | SLC1A3, GNG10, GLUL | More | | Voxelotor | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Voxelotor | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Voxelotor | hsa04810 | Regulation of actin cytoskeleton | 2.84E-02 | 7 | P00734, P61586, Q02750, P23229, P26012, P60709, P63261 | F2, RHOA, MAP2K1, ITGA6, ITGB8, ACTB, ACTG1 | More | | Voxelotor | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Voxelotor | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Voxelotor | hsa04914 | Progesterone-mediated oocyte maturation | 2.97E-03 | 6 | Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | | Voxelotor | hsa04915 | Estrogen signaling pathway | 2.75E-03 | 5 | Q99941, P18848, P51828, P07900, P11142 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | | Voxelotor | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Voxelotor | hsa04919 | Thyroid hormone signaling pathway | 2.73E-03 | 7 | Q02750, P26678, P60709, P63261, Q09472, P08237, P01106 | MAP2K1, PLN, ACTB, ACTG1, EP300, PFKM, MYC | More | | Voxelotor | hsa04921 | Oxytocin signaling pathway | 1.22E-02 | 6 | Q02750, P60660, P60709, P63261, P61586, P54284 | MAP2K1, MYL6, ACTB, ACTG1, RHOA, CACNB3 | More | | Voxelotor | hsa04924 | Renin secretion | 3.77E-02 | 2 | Q13370, P0DP23 | PDE3B, CALM1 | More | | Voxelotor | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Voxelotor | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Voxelotor | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Voxelotor | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Voxelotor | hsa04931 | Insulin resistance | 3.18E-04 | 3 | Q9Y4H2, P36956, Q13133 | IRS2, SREBF1, NR1H3 | More | | Voxelotor | hsa04932 | Non-alcoholic fatty liver disease | 4.74E-04 | 3 | Q9Y4H2, P36956, Q13133 | IRS2, SREBF1, NR1H3 | More | | Voxelotor | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Voxelotor | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Voxelotor | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Voxelotor | hsa04966 | Collecting duct acid secretion | 3.44E-02 | 2 | P02730, P00918 | SLC4A1, CA2 | More | | Voxelotor | hsa04972 | Pancreatic secretion | 1.99E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Voxelotor | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Voxelotor | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Voxelotor | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Voxelotor | hsa05032 | Morphine addiction | 1.27E-02 | 4 | P63218, P50151, Q07343, P43250 | GNG5, GNG10, PDE4B, GRK6 | More | | Voxelotor | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Voxelotor | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 8.38E-04 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Voxelotor | hsa05130 | Pathogenic Escherichia coli infection | 1.31E-02 | 8 | P61586, P19338, Q13885, P60709, P63261, Q12933, P00734, O95487 | RHOA, NCL, TUBB2A, ACTB, ACTG1, TRAF2, F2, SEC24B | More | | Voxelotor | hsa05132 | Salmonella infection | 1.43E-03 | 11 | Q9UJU2, P63261, Q13546, Q13489, P10415, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | LEF1, ACTG1, RIPK1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Voxelotor | hsa05133 | Pertussis | 1.96E-02 | 3 | P10145, P23528, P0C0L4 | IL8, CFL1, C4A | More | | Voxelotor | hsa05135 | Yersinia infection | 9.76E-03 | 7 | P60709, P63261, P61586, Q16513, P51812, Q12933, Q02750 | ACTB, ACTG1, RHOA, PKN2, RPS6KA3, TRAF2, MAP2K1 | More | | Voxelotor | hsa05140 | Leishmaniasis | 2.75E-05 | 8 | P13612, O75015, P14598, P13765, O60603, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, HLA-DOB, TLR2, MARCKSL1, MAPK14, NCF4 | More | | Voxelotor | hsa05146 | Amoebiasis | 4.55E-02 | 5 | P09341, P14778, P27930, O60603, P05089 | CXCL1, IL1R1, IL1R2, TLR2, ARG1 | More | | Voxelotor | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Voxelotor | hsa05163 | Human cytomegalovirus infection | 3.64E-02 | 7 | Q14643, P49841, P14778, P25025, Q16539, P04637, O00463 | ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5 | More | | Voxelotor | hsa05164 | Influenza A | 8.79E-03 | 8 | Q09472, P48551, P29728, O15131, Q02750, P60709, P63261, Q9BUJ2 | EP300, IFNAR2, OAS2, KPNA5, MAP2K1, ACTB, ACTG1, HNRPUL1 | More | | Voxelotor | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | | Voxelotor | hsa05168 | Herpes simplex virus 1 infection | 1.15E-02 | 8 | P42224, Q07955, Q01130, Q13243, P42338, Q13398, Q03923, Q9UDV6 | STAT1, SFRS1, SFRS2, SFRS5, PIK3CB, ZNF211, ZNF85, ZNF212 | More | | Voxelotor | hsa05170 | Human immunodeficiency virus 1 infection | 6.02E-03 | 5 | Q02750, P62879, P16298, Q05397, P20333 | MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1B | More | | Voxelotor | hsa05171 | Coronavirus disease - COVID-19 | 3.87E-04 | 5 | P62249, P40429, P27635, Q07020, P05386 | RPS16, RPL13A, RPL10, RPL18, RPLP1 | More | | Voxelotor | hsa05200 | Pathways in cancer | 1.31E-03 | 21 | Q13751, P42338, P08238, P42224, P19174, P43246, P84022, Q13485, Q13547, P14923, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 |
| Voxelotor | hsa05202 | Transcriptional misregulation in cancer | 6.80E-03 | 12 | Q12778, Q15532, P41732, P14780, P14923, Q13489, O15550, P04637, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, TSPAN7, MMP9, JUP, BIRC3, UTX, TP53, MPO, ELA2, BCL11B, GADD45A | More | | Voxelotor | hsa05203 | Viral carcinogenesis | 3.30E-06 | 10 | Q99941, P18848, P27348, Q15283, Q12834, P61978, P62807, P33778, Q16778, O60814 | CREBL1, ATF4, YWHAQ, RASA2, CDC20, HNRPK, HIST1H2BC, H2BC3, HIST2H2BE, H2BC12 | More | | Voxelotor | hsa05204 | Chemical carcinogenesis | 1.09E-03 | 3 | P09211, P78417, P11712 | GSTP1, GSTO1, CYP2C9 | More | | Voxelotor | hsa05205 | Proteoglycans in cancer | 2.66E-02 | 8 | Q14643, P63261, P04637, P14780, P17252, O60603, Q13635, P08962 | ITPR1, ACTG1, TP53, MMP9, PRKCA, TLR2, PTCH1, CD63 | More | | Voxelotor | hsa05212 | Pancreatic cancer | 2.14E-03 | 5 | P42338, P42224, P84022, Q13485, O75293 | PIK3CB, STAT1, SMAD3, SMAD4, GADD45B | More | | Voxelotor | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Voxelotor | hsa05214 | Glioma | 1.72E-02 | 3 | P0DP23, P42338, O75293 | CALM1, PIK3CB, GADD45B | More | | Voxelotor | hsa05216 | Thyroid cancer | 3.59E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Voxelotor | hsa05217 | Basal cell carcinoma | 1.46E-02 | 4 | Q13635, Q9UJU2, P04637, P24522 | PTCH1, LEF1, TP53, GADD45A | More | | Voxelotor | hsa05219 | Bladder cancer | 1.81E-03 | 2 | P14780, P04637 | MMP9, TP53 | More | | Voxelotor | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Voxelotor | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Voxelotor | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Voxelotor | hsa05230 | Central carbon metabolism in cancer | 1.09E-03 | 5 | P01106, P09619, Q02750, P19367, P08237 | MYC, PDGFRB, MAP2K1, HK1, PFKM | More | | Voxelotor | hsa05231 | Choline metabolism in cancer | 2.71E-02 | 4 | Q02750, P09619, O15245, P35790 | MAP2K1, PDGFRB, SLC22A1, CHKA | More | | Voxelotor | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.55E-02 | 5 | O95267, P09693, O60603, Q16539, P01730 | RASGRP1, CD3G, TLR2, MAPK14, CD4 | More | | Voxelotor | hsa05322 | Systemic lupus erythematosus | 4.71E-07 | 7 | P09871, Q93077, P62807, P33778, Q16778, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC3, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Voxelotor | hsa05323 | Rheumatoid arthritis | 3.53E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Voxelotor | hsa05410 | Hypertrophic cardiomyopathy | 1.48E-06 | 9 | Q8IZS8, P54284, P23229, P13612, P26012, P09493, Q8WZ42, P60709, P63261 | CACNA2D3, CACNB3, ITGA6, ITGA4, ITGB8, TPM1, TTN, ACTB, ACTG1 | More | | Voxelotor | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.08E-07 | 8 | Q8IZS8, P54284, P15924, P23229, P13612, P26012, P60709, P63261 | CACNA2D3, CACNB3, DSP, ITGA6, ITGA4, ITGB8, ACTB, ACTG1 | More | | Voxelotor | hsa05414 | Dilated cardiomyopathy | 6.73E-07 | 10 | Q8IZS8, P54284, P23229, P13612, P26012, P09493, Q8WZ42, P26678, P60709, P63261 | CACNA2D3, CACNB3, ITGA6, ITGA4, ITGB8, TPM1, TTN, PLN, ACTB, ACTG1 | More | | Voxelotor | hsa05418 | Fluid shear stress and atherosclerosis | 3.97E-04 | 13 | Q16539, P42338, P14598, P10599, P14780, P63261, P04637, P10415, P14778, P27930, P0DP23, P08238, Q92974 | MAPK14, PIK3CB, NCF1, TXN, MMP9, ACTG1, TP53, BCL2, IL1R1, IL1R2, CALM1, HSP90AB1, ARHGEF2 | More | | |